
Rudy Yakym Periodic Transaction Report
Filed Oct 12, 2023 · House Clerk · 1 transaction
U.S. Representative · R · IN-02 · All trades by Rudy Yakym
On October 12, 2023, Rep. Rudy Yakym (R-IN-02) filed a periodic transaction report with the House Clerk disclosing 1 transaction (1 purchase) dated Oct 12, 2023.
None of the reported assets carry a stock ticker (bonds, funds, or private holdings).
Reported amount ranges sum to $50K–$100K. Congress reports trade sizes in ranges, not exact figures.
Every trade was reported within the STOCK Act's 45-day window. The longest lag in this filing was 0 days.
Source document: House Clerk filing 20023843
Sample · the intelligence layer
Rudy Yakym · Bought · Oct 12 · $50K–$100K
Coldpine’s read
Same-day disclosure is unusually fast, though the asset—a short-dated T-bill maturing in under 90 days—carries minimal information value beyond cash management. The purchase aligns with elevated front-end yields during the October 2023 rate environment, a common parking vehicle rather than a directional bet. Yakym's Ways and Means seat touches tax and debt policy, but no cluster activity suggests this is idiosyncratic personal liquidity management.
Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →
Follow Rudy Yakym
Get an email the moment Rudy Yakym files the next one. Free, no card, no spam.
Transactions disclosed
| Trade date | Ticker | Asset | Type | Owner | Amount | Lag |
|---|---|---|---|---|---|---|
| Oct 12, 2023 | — | Treasury Bill (13-Week, Matures 01/11/2024) [GS] | buy | — | $50K–$100K | 0d |
Other recent filings by Rudy Yakym
- PTR filed Apr 6, 20261 trade
- PTR filed Dec 23, 20251 trade
- PTR filed Aug 18, 20251 trade
- PTR filed May 8, 20251 trade
- PTR filed Jan 28, 20251 trade
- PTR filed Dec 3, 20241 trade
← All congressional filings, newest first
From Coldpine Research
Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →